Aquestive Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AQST and other ETFs, options, and stocks.

About AQST

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz.

CEO

Daniel Barber

CEODaniel Barber

Employees

142

Employees142

Headquarters

Warren, New Jersey

HeadquartersWarren, New Jersey

Founded

2004

Founded2004

Employees

142

Employees142

AQST Key Statistics

Market cap

277.83M

Market cap277.83M

Price-Earnings ratio

-5.45

Price-Earnings ratio-5.45

Dividend yield

—

Dividend yield—

Average volume

1.29M

Average volume1.29M

High today

$2.97

High today$2.97

Low today

$2.77

Low today$2.77

Open price

$2.82

Open price$2.82

Volume

1.26M

Volume1.26M

52 Week high

$5.80

52 Week high$5.80

52 Week low

$2.20

52 Week low$2.20

Analyst ratings

100%

of 9 ratings

Buy

100%

Hold

Sell

Aquestive Therapeutics

Why Robinhood?

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. Show more

AQST Key Statistics

Analyst ratings

100%

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz.